The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine. The financial package will fund the expansion of ...
Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine as concerns about a bird flu pandemic in humans ...
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
The current public-health risk is low, but the CDC is watching the situation carefully and working with states to monitor ...
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
Robert F. Kennedy Jr. petitioned the FDA to revoke authorization of the shots when they were in high demand and thousands of ...
Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of ...
Moderna Inc (MRNA) stock saw a decline, ending the day at $33.76 which represents a decrease of $-1.01 or -2.90% from the prior close of $34.77. The stock opened at $34.75 and touched a low of $33.34 ...
Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.
Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a ...
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...